Exploring Novel Endpoints for Clinical Trials in Kidney Disease: Challenges and Opportunities

Kidney International Reports - United States
doi 10.1016/j.ekir.2017.04.001
Full Text
Abstract

Available in full text

Categories
Nephrology
Date
Authors
Publisher

Elsevier BV

Related search

Challenges Assessing Clinical Endpoints in Early Huntington Disease

Movement Disorders
Neurology
2010English

Design and Endpoints for Clinical Trials in Primary Sclerosing Cholangitis

Hepatology
MedicineHepatology
2018English

Defining Surrogate Endpoints for Clinical Trials in Severe Falciparum Malaria

PLoS ONE
Multidisciplinary
2017English

Patients’ Preferences for Selection of Endpoints in Cardiovascular Clinical Trials

Journal of Community Hospital Internal Medicine Perspectives
Internal Medicine
2014English

Development of Standard Clinical Endpoints for Use in Dengue Interventional Trials

PLoS Neglected Tropical Diseases
PharmacologyPublic HealthEnvironmentalToxicologyInfectious DiseasesPharmaceuticsOccupational Health
2018English

Surrogate End Points for Clinical Trials of Kidney Disease Progression

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2006English

Feast and Famine: Epidemiology and Clinical Trials in Chronic Kidney Disease

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2007English

A Perspective on Surrogate Endpoints in Controlled Clinical Trials

Statistical Methods in Medical Research
Health Information ManagementEpidemiologyStatisticsProbability
2004English

Exploring China’s Arctic Strategy: Opportunities and Challenges

China Quarterly of International Strategic Studies
SociologyInternational RelationsPolitical Science
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy